1. Home
  2. ADAP vs YOSH Comparison

ADAP vs YOSH Comparison

Compare ADAP & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • YOSH
  • Stock Information
  • Founded
  • ADAP 2008
  • YOSH 2016
  • Country
  • ADAP United Kingdom
  • YOSH United States
  • Employees
  • ADAP N/A
  • YOSH N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • ADAP Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • ADAP 21.3M
  • YOSH 23.7M
  • IPO Year
  • ADAP 2015
  • YOSH 2022
  • Fundamental
  • Price
  • ADAP $0.06
  • YOSH $1.49
  • Analyst Decision
  • ADAP Hold
  • YOSH
  • Analyst Count
  • ADAP 6
  • YOSH 0
  • Target Price
  • ADAP $1.02
  • YOSH N/A
  • AVG Volume (30 Days)
  • ADAP 89.0M
  • YOSH 370.7K
  • Earning Date
  • ADAP 08-13-2025
  • YOSH 08-20-2025
  • Dividend Yield
  • ADAP N/A
  • YOSH N/A
  • EPS Growth
  • ADAP N/A
  • YOSH N/A
  • EPS
  • ADAP N/A
  • YOSH N/A
  • Revenue
  • ADAP $65,084,999.00
  • YOSH $13,902,861.00
  • Revenue This Year
  • ADAP N/A
  • YOSH N/A
  • Revenue Next Year
  • ADAP $52.35
  • YOSH N/A
  • P/E Ratio
  • ADAP N/A
  • YOSH N/A
  • Revenue Growth
  • ADAP N/A
  • YOSH 30.39
  • 52 Week Low
  • ADAP $0.05
  • YOSH $0.68
  • 52 Week High
  • ADAP $1.33
  • YOSH $5.63
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 29.42
  • YOSH 32.43
  • Support Level
  • ADAP $0.05
  • YOSH $1.57
  • Resistance Level
  • ADAP $0.09
  • YOSH $1.63
  • Average True Range (ATR)
  • ADAP 0.01
  • YOSH 0.13
  • MACD
  • ADAP 0.00
  • YOSH -0.00
  • Stochastic Oscillator
  • ADAP 7.21
  • YOSH 4.69

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: